Skip to main navigation Skip to search Skip to main content

A Phase I/II Study of the Combination of Panobinostat (PAN) and Carfilzomib (CFZ) in Patients (pts) with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Comparison of Two Expansion Cohorts

  • Jesus G. Berdeja
  • , Tara B. Gregory
  • , Edward A. Faber
  • , Jeffrey V. Matous
  • , Lowell L. Hart
  • , Joseph R. Mace
  • , James D. Peyton
  • , James H. Essell
  • , Edward R. Arrowsmith
  • , Ian W. Flinn
  • Sarah Cannon Research Institute

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume126
Issue number23
DOIs
StatePublished - Dec 3 2015
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Internal Medicine

Cite this